A Phase 1 Study to Evaluate Safety, Tolerability and Pharmacokinetics of TIX100 in Healthy Subjects
Clinical trial NCT06800729 · RECRUITING
Trial details
- NCT number
- NCT06800729
- Sponsor
- TIXiMED, Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-01
- Primary completion
- 2025-05-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.